Drug Shortage Report for TRANEXAMIC ACID INJECTION BP

Last updated on 2021-02-09 History
Report ID 131839
Drug Identification Number 02246365
Brand name TRANEXAMIC ACID INJECTION BP
Common or Proper name TRANEXAMIC ACID INJECTION USP
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TRANEXAMIC ACID
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10ML 10LIVI CA
ATC code B02AA
ATC description ANTIFIBRINOLYTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-01-15
Estimated end date 2021-02-05
Actual end date 2021-02-08
Shortage status Resolved
Updated date 2021-02-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-02-09 English Compare
v4 2021-02-08 French Compare
v3 2021-02-08 English Compare
v2 2021-01-18 French Compare
v1 2021-01-18 English Compare

Showing 1 to 5 of 5